Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
Title:
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
Author:
Camps, C. Massuti, B. Jiménez, A. Maestu, I. Gómez, R. García Isla, D. González, J.L. Almenar, D. Blasco, A. Rosell, R. Carrato, A. Viñolas, N. Batista, N. Girón, C. García Galán, A. López, M. Blanco, R. Provencio, M. Diz, P. Felip, E.